BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 18677826)

  • 21. The family physician as medical review officer.
    McKnight JT; Wheat JR
    J Am Board Fam Pract; 1995; 8(1):29-33. PubMed ID: 7701957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug and alcohol testing. DOT's, Part 40: Implications for employers.
    Eden T
    Occup Health Saf; 2000 Jul; 69(7):84-6, 88. PubMed ID: 10902123
    [No Abstract]   [Full Text] [Related]  

  • 23. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice.
    Fed Regist; 1990 Dec; 55(238):50882-3. PubMed ID: 10128595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Finnish legislation on workplace drug testing.
    Lamberg ME; Kangasperko R; Partinen R; Lillsunde P; Mukala K; Haavanlammi K
    Forensic Sci Int; 2008 Jan; 174(2-3):95-8. PubMed ID: 17498899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do we have the training? The ethics of workplace drug testing and the GP.
    Evans A; Thornett A
    Aust Fam Physician; 2003 Aug; 32(8):645-7. PubMed ID: 12973876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview on drug and alcohol testing in the workplace.
    Hanson M
    Bull Narc; 1993; 45(2):3-44. PubMed ID: 7920541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-drug program for personnel engaged in specified aviation activities--Federal Aviation Administration. Final rule.
    Fed Regist; 1991 Sep; 56(172):43974-6. PubMed ID: 10170821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current practice and experience in drug and alcohol testing in the workplace.
    Zwerling C
    Bull Narc; 1993; 45(2):155-96. PubMed ID: 7920540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectious substances--DOT. Final rule.
    Fed Regist; 1995 Sep; 60(182):48780-7. PubMed ID: 10151186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infectious substances (etiologic agents); revisions to transitional provisions--Department of Transportation. Final rule; partial response to petition for reconsideration.
    Fed Regist; 1991 Oct; 56(190):49830-1. PubMed ID: 10114372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Finnish guidelines for workplace drug testing.
    Lillsunde P; Haavanlammi K; Partinen R; Mukala K; Lamberg M
    Forensic Sci Int; 2008 Jan; 174(2-3):99-102. PubMed ID: 17499950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Special report. Drug testing in the workplace: an update.
    Hosp Secur Saf Manage; 1994 Oct; 15(6):5-9. PubMed ID: 10137771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicaid program: rescission of School-Based Administration/Transportation final rule, Outpatient Hospital Services final rule, and partial rescission of Case Management Interim final rule. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2009 Jun; 74(124):31183-96. PubMed ID: 19588575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies, and laboratories that have withdrawn from the program--SAMHSA. Notice.
    Fed Regist; 1998 Feb; 63(21):5394-6. PubMed ID: 10177334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for drugs of abuse: hair as an alternative matrix: a review for the medical toxicologist.
    Curtis J; Greenberg M
    Clin Toxicol (Phila); 2008 Jan; 46(1):22-34. PubMed ID: 18167034
    [No Abstract]   [Full Text] [Related]  

  • 36. Performance-oriented packaging standards; revisions to transitional provisions--Department of Transportation. Final rule; partial response to petitions for reconsideration and revisions.
    Fed Regist; 1991 Sep; 56(181):47158-63. PubMed ID: 10114364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public policy statement on drug testing as a component of addiction treatment and monitoring programs and in other clinical settings.
    J Addict Dis; 2003; 22(3):114-9. PubMed ID: 14621351
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical application of ethyl glucuronide testing in the U.S. Army.
    Lande RG; Marin B; Chang AS
    J Addict Dis; 2011 Jan; 30(1):39-44. PubMed ID: 21218309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minnesota workplace drug testing. Analysis of policy and procedures.
    Reynolds JL; McGovern PM; Kochevar L; Olson DK; Hibbs BF
    AAOHN J; 1991 Nov; 39(11):523-33. PubMed ID: 1930387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urine specimen validity test for drug abuse testing in workplace and court settings.
    Lin SY; Lee HH; Lee JF; Chen BH
    J Food Drug Anal; 2018 Jan; 26(1):380-384. PubMed ID: 29389577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.